SCHEMBL3280929

SCHEMBL3280929

O=C(O)Nc1ccsc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16333615 0.80 LCK (0.43)
SCHEMBL17082813 0.79
SCHEMBL7438683 0.79
SCHEMBL568863 0.79
SCHEMBL8847816 0.79
SCHEMBL568862 0.79
SCHEMBL4131287 0.79
SCHEMBL4481913 0.77 HPGD (0.71)
SCHEMBL8847819 0.76
SCHEMBL14606348 0.76 HPGD (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1732923-A2 MUSCARINIC ACETYLCHOLINE RECEPTOR ANTAGONISTS GLAXO GROUP LIMITED (GB) 2006-12-20 EP claimed
EP-1353926-B1 MIKANOLIDE DERIVATIVES, THEIR PREPARATION AND THERAPEUTIC USES SOD CONSEILS RECH APPLIC (FR) 2006-03-08 EP claimed
CN-1234711-C Mikanolide derivatives, their preparation and their therapeutic use CONSEILS DE RECH R ET D APPLIC (FR) 2006-01-04 CN claimed
CN-1691941-A Product containing mikanolide, dihydromikanolide or its analogue and another anticancer agent for treating cancer SOD CONSEILS RECH APPLIC (FR) 2005-11-02 CN claimed
WO-2005099706-A2 MUSCARINIC ACETYLCHOLINE RECEPTOR ANTAGONISTS GLAXO GROUP LIMITED (GB) 2005-10-27 WO claimed
JP-2004533456-A 2004-11-04 JP claimed
EP-1438039-A2 PRODUCT COMPRISING MIKANOLIDE, DIHYDROMIKANOLIDE OR AN ANALOGUE THEREOF COMBINED WITH ANOTHER ANTI-CANCER AGENT FOR THERAPEUTIC USE IN CANCER TREATMENT SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) (FR) 2004-07-21 EP claimed
CN-1484646-A Mikanolide derivatives, their preparation and their therapeutic use ��ѧ�о���Ӧ����ѯ��˾ 2004-03-24 CN claimed
EP-1353926-A1 MIKANOLIDE DERIVATIVES, THEIR PREPARATION AND THERAPEUTIC USES Société de Conseils de Recherches et d'Applications Scientifiques ( S.C.R.A.S.) (FR) 2003-10-22 EP claimed
WO-2002096348-A2 PRODUCT COMPRISING MIKANOLIDE, DIHYDROMIKANOLIDE OR AN ANALOGUE THEREOF COMBINED WITH ANOTHER ANTI-CANCER AGENT FOR THERAPEUTIC USE IN CANCER TREATMENT SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) (FR) 2002-12-05 WO claimed
WO-2002055523-A1 MIKANOLIDE DERIVATIVES, THEIR PREPARATION AND THERAPEUTIC USES SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) (FR) 2002-07-18 WO claimed
WO-2026087399-A1 2-(4-PIPERIDYL)-6-(IMIDAZO[1,2-B]PYRIDAZIN-6-YL)THIENO[3,2-B]PYRIDINE DERIVATIVES THAT REDUCE THE PROTEIN LEVEL OF HUNTINGTIN (HTT) FOR THE TREATMENT OF HUNTINGTON'S DISEASE F. HOFFMANN-LA ROCHE AG (CH) 2026-04-30 WO disclosed
EP-4698541-A1 THIENO[3,2-B]PYRIDINE DERIVATIVES F. Hoffmann-La Roche AG (CH) 2026-02-25 EP disclosed
US-12454530-B2 Amido cyclohexane acid derivatives as LPA receptor inhibitors CHIESI FARMACEUTICI S.P.A. (IT) 2025-10-28 US disclosed
WO-2025085233-A1 NOVEL DERIVATIVES OF QUINOLINONES, AND COMPOSITIONS AND METHODS THEREOF ENSEM THERAPEUTICS, INC. (US) 2025-04-24 WO disclosed
EP-0633259-B1 Sulfonylaminopyrimidines, their preparation and their use as medicine HOFFMANN LA ROCHE (CH) 1999-01-13 EP disclosed
US-5637731-A CHOLINERGIC AGENTS AMERICAN HOME PRODUCTS CORPORATION (US) 1997-06-10 US disclosed
US-5550257-A TREATING CENTRAL CHOLINERGIC DYSFUNCTION AMERICAN CYANAMID COMPANY (US) 1996-08-27 US disclosed
US-5541186-A ENDOTHELIN RECEPTOR INHIBITORS HOFFMANN-LA ROCHE INC. (US) 1996-07-30 US disclosed
EP-0633259-A1 Sulfonylaminopyrimidines, their preparation and their use as medicine F. HOFFMANN-LA ROCHE AG (CH) 1995-01-11 EP disclosed